+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Hemophilia Treatment Market Research Report by Product Type, Disease Indication, Distribution, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 237 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4829909
UP TO OFF until Dec 31st 2022
The Global Hemophilia Treatment Market size was estimated at USD 12.69 billion in 2021, USD 13.47 billion in 2022, and is projected to grow at a CAGR 6.34% to reach USD 18.35 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Hemophilia Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product Type, the market was studied across Antifibrinolytic Agents, Desmopressin, Plasma Derived Coagulation Factor Concentrates, and Recombinant Coagulation Factor Concentrates.
  • Based on Disease Indication, the market was studied across Hemophilia A, Hemophilia B, and Polyethylene.
  • Based on Distribution, the market was studied across E-commerce, Hospital Pharmacies, and Retail Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Hemophilia Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hemophilia Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hemophilia Treatment Market, including Baxter International, Inc., Bayer AG, Biogen Inc., Biotest AG, Chugai Pharmaceutical Co., Ltd., CSL Ltd., Genentech, Inc., Grifols S.A., Kedrion Biopharma Inc., Novo Nordisk A/S, Octapharma AG, Pfizer, Inc., Shire Plc, Spark Therapeutics, Inc., and Swedish Orphan Biovitrum AB.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Hemophilia Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hemophilia Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hemophilia Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Hemophilia Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Hemophilia Treatment Market?
6. What is the market share of the leading vendors in the Global Hemophilia Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Hemophilia Treatment Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising diagnostic and awareness related to Hemophilia
5.1.1.2. Increasing demand for recombinant and plasma-derived factor VIII and factor IX
5.1.2. Restraints
5.1.2.1. Serious adverse effects associated with plasma-derived products
5.1.2.2. Stringent government regulations
5.1.3. Opportunities
5.1.3.1. Increased diagnosis rate and rise in the use of prophylactic treatment
5.1.4. Challenges
5.1.4.1. High cost of recombinant products
5.2. Cumulative Impact of COVID-19
6. Hemophilia Treatment Market, by Product Type
6.1. Introduction
6.2. Antifibrinolytic Agents
6.3. Desmopressin
6.4. Plasma Derived Coagulation Factor Concentrates
6.5. Recombinant Coagulation Factor Concentrates
7. Hemophilia Treatment Market, by Disease Indication
7.1. Introduction
7.2. Hemophilia A
7.3. Hemophilia B
7.4. Polyethylene
8. Hemophilia Treatment Market, by Distribution
8.1. Introduction
8.2. E-commerce
8.3. Hospital Pharmacies
8.4. Retail Pharmacies
9. Americas Hemophilia Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hemophilia Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Hemophilia Treatment Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Baxter International, Inc.
13.2. Bayer AG
13.3. Biogen Inc.
13.4. Biotest AG
13.5. Chugai Pharmaceutical Co., Ltd.
13.6. CSL Ltd.
13.7. Genentech, Inc.
13.8. Grifols S.A.
13.9. Kedrion Biopharma Inc.
13.10. Novo Nordisk A/S
13.11. Octapharma AG
13.12. Pfizer, Inc.
13.13. Shire Plc
13.14. Spark Therapeutics, Inc.
13.15. Swedish Orphan Biovitrum AB
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL HEMOPHILIA TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, 2021 VS 2027 (USD BILLION)
FIGURE 3. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 4. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL HEMOPHILIA TREATMENT MARKET DYNAMICS
FIGURE 8. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2027
FIGURE 11. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY ANTIFIBRINOLYTIC AGENTS, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY ANTIFIBRINOLYTIC AGENTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DESMOPRESSIN, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DESMOPRESSIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, 2019-2027 (USD BILLION)
FIGURE 18. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2021 VS 2027 (%)
FIGURE 20. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2021 VS 2027 (USD BILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2027
FIGURE 22. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA A, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA B, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA B, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY POLYETHYLENE, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY POLYETHYLENE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 29. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD BILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2027
FIGURE 31. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY E-COMMERCE, 2019-2027 (USD BILLION)
FIGURE 32. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 33. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2019-2027 (USD BILLION)
FIGURE 34. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 35. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2019-2027 (USD BILLION)
FIGURE 36. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 37. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 38. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 39. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 41. ARGENTINA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. BRAZIL HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. CANADA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. MEXICO HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 47. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY STATE, 2027
FIGURE 49. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 51. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 53. AUSTRALIA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. CHINA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. INDIA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. INDONESIA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. JAPAN HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. MALAYSIA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. PHILIPPINES HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. SINGAPORE HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. SOUTH KOREA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. TAIWAN HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. THAILAND HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 67. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 68. FRANCE HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. GERMANY HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. ITALY HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 71. NETHERLANDS HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 72. QATAR HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 73. RUSSIA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 74. SAUDI ARABIA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 75. SOUTH AFRICA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 76. SPAIN HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 77. UNITED ARAB EMIRATES HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 78. UNITED KINGDOM HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 79. GLOBAL HEMOPHILIA TREATMENT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 80. GLOBAL HEMOPHILIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 81. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HEMOPHILIA TREATMENT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL HEMOPHILIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 6. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY ANTIFIBRINOLYTIC AGENTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 7. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY ANTIFIBRINOLYTIC AGENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY ANTIFIBRINOLYTIC AGENTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 9. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY ANTIFIBRINOLYTIC AGENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY ANTIFIBRINOLYTIC AGENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DESMOPRESSIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 12. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY DESMOPRESSIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY DESMOPRESSIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 14. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY DESMOPRESSIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY DESMOPRESSIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, BY REGION, 2019-2027 (USD BILLION)
TABLE 17. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, BY STATE, 2019-2027 (USD BILLION)
TABLE 19. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, BY REGION, 2019-2027 (USD BILLION)
TABLE 22. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, BY STATE, 2019-2027 (USD BILLION)
TABLE 24. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 27. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2019-2027 (USD BILLION)
TABLE 28. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA A, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA A, BY STATE, 2019-2027 (USD BILLION)
TABLE 30. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA A, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA A, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 32. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA B, BY REGION, 2019-2027 (USD BILLION)
TABLE 33. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA B, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA B, BY STATE, 2019-2027 (USD BILLION)
TABLE 35. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA B, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY HEMOPHILIA B, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 37. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY POLYETHYLENE, BY REGION, 2019-2027 (USD BILLION)
TABLE 38. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY POLYETHYLENE, BY STATE, 2019-2027 (USD BILLION)
TABLE 40. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 43. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2019-2027 (USD BILLION)
TABLE 44. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY E-COMMERCE, BY STATE, 2019-2027 (USD BILLION)
TABLE 46. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 48. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 49. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 51. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 53. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 54. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 56. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 58. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 59. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 61. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 62. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 63. ARGENTINA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 64. ARGENTINA HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 65. ARGENTINA HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 66. ARGENTINA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 67. BRAZIL HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 68. BRAZIL HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 69. BRAZIL HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 70. BRAZIL HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 71. CANADA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 72. CANADA HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 73. CANADA HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 74. CANADA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 75. MEXICO HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 76. MEXICO HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 77. MEXICO HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 78. MEXICO HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 79. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 80. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
TABLE 81. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 82. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 83. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 84. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 85. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 86. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 87. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 88. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 89. AUSTRALIA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 90. AUSTRALIA HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 91. AUSTRALIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 92. AUSTRALIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 93. CHINA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. CHINA HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 95. CHINA HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 96. CHINA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 97. INDIA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 98. INDIA HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 99. INDIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 100. INDIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 101. INDONESIA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 102. INDONESIA HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 103. INDONESIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 104. INDONESIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 105. JAPAN HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 106. JAPAN HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 107. JAPAN HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 108. JAPAN HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 109. MALAYSIA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 110. MALAYSIA HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 111. MALAYSIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 112. MALAYSIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 113. PHILIPPINES HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 114. PHILIPPINES HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 115. PHILIPPINES HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 116. PHILIPPINES HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 117. SINGAPORE HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 118. SINGAPORE HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 119. SINGAPORE HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 120. SINGAPORE HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 121. SOUTH KOREA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 122. SOUTH KOREA HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 123. SOUTH KOREA HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 124. SOUTH KOREA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 125. TAIWAN HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 126. TAIWAN HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 127. TAIWAN HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 128. TAIWAN HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 129. THAILAND HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 130. THAILAND HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 131. THAILAND HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 132. THAILAND HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 138. FRANCE HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 139. FRANCE HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 140. FRANCE HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 141. FRANCE HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 142. GERMANY HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 143. GERMANY HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 144. GERMANY HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 145. GERMANY HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 146. ITALY HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 147. ITALY HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 148. ITALY HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 149. ITALY HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 150. NETHERLANDS HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 151. NETHERLANDS HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 152. NETHERLANDS HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 153. NETHERLANDS HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 154. QATAR HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 155. QATAR HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 156. QATAR HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 157. QATAR HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 158. RUSSIA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 159. RUSSIA HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 160. RUSSIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 161. RUSSIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 162. SAUDI ARABIA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 163. SAUDI ARABIA HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 164. SAUDI ARABIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 165. SAUDI ARABIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 166. SOUTH AFRICA HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 167. SOUTH AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 168. SOUTH AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 169. SOUTH AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 170. SPAIN HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 171. SPAIN HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 172. SPAIN HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 173. SPAIN HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 174. UNITED ARAB EMIRATES HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 175. UNITED ARAB EMIRATES HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 176. UNITED ARAB EMIRATES HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 177. UNITED ARAB EMIRATES HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 178. UNITED KINGDOM HEMOPHILIA TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 179. UNITED KINGDOM HEMOPHILIA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 180. UNITED KINGDOM HEMOPHILIA TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2019-2027 (USD BILLION)
TABLE 181. UNITED KINGDOM HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 182. GLOBAL HEMOPHILIA TREATMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 183. GLOBAL HEMOPHILIA TREATMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 184. GLOBAL HEMOPHILIA TREATMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 185. GLOBAL HEMOPHILIA TREATMENT MARKET RANKING
TABLE 186. GLOBAL HEMOPHILIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
TABLE 187. GLOBAL HEMOPHILIA TREATMENT MARKET MERGER & ACQUISITION
TABLE 188. GLOBAL HEMOPHILIA TREATMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 189. GLOBAL HEMOPHILIA TREATMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 190. GLOBAL HEMOPHILIA TREATMENT MARKET INVESTMENT & FUNDING
TABLE 191. GLOBAL HEMOPHILIA TREATMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 192. GLOBAL HEMOPHILIA TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • Baxter International, Inc.
  • Bayer AG
  • Biogen Inc.
  • Biotest AG
  • Chugai Pharmaceutical Co., Ltd.
  • CSL Ltd.
  • Genentech, Inc.
  • Grifols S.A.
  • Kedrion Biopharma Inc.
  • Novo Nordisk A/S
  • Octapharma AG
  • Pfizer, Inc.
  • Shire Plc
  • Spark Therapeutics, Inc.
  • Swedish Orphan Biovitrum AB

Methodology

Loading
LOADING...